{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T14:51:28Z","timestamp":1774882288058,"version":"3.50.1"},"reference-count":88,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004054","name":"King Abdulaziz University","doi-asserted-by":"publisher","award":["KEP-42-130-39"],"award-info":[{"award-number":["KEP-42-130-39"]}],"id":[{"id":"10.13039\/501100004054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/15\/72\/31676"],"award-info":[{"award-number":["FS\/15\/72\/31676"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Hypertensive disorder in pregnancy is a major cause of maternal and perinatal mortality worldwide. Women who have had preeclampsia are at three to four times higher risk in later life of developing high blood pressure and heart disease. Soluble Flt-1 (sFlt-1) is elevated in preeclampsia and may remain high postpartum in women with a history of preeclampsia. Heme oxygenase-1 (Hmox1\/HO-1) exerts protective effects against oxidative stimuli and is compromised in the placenta of pregnant women with preeclampsia. We hypothesized that sFlt-1 inhibits cardiac mitochondrial activity in HO-1 deficient mice. HO-1 haplo-insufficient mice (Hmox1+\/\u2212) were injected with adenovirus encoding sFlt-1 (Ad-sFlt-1) or control virus (Ad-CMV). Subsequently, they were treated daily with either placebo or MZe786 for six days, when the heart tissue was harvested to assess cardiac mitochondrial activity. Here, we show that the loss of HO-1 disturbed cardiac mitochondrial respiration and reduced mitochondrial biogenesis. The overexpression of sFlt-1 resulted in the inhibition of the cardiac mitochondrial activity in Hmox1+\/\u2212 mice. The present study demonstrates that the hydrogen sulfide (H2S) releasing molecule, MZe786, rescues mitochondrial activity by stimulating cardiac mitochondrial biogenesis and antioxidant defense in Hmox1\u2212\/\u2212 mice and in Hmox1+\/\u2212 mice exposed to a high sFlt-1 environment.<\/jats:p>","DOI":"10.3390\/antiox9070598","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T10:45:19Z","timestamp":1594291519000},"page":"598","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["MZe786 Rescues Cardiac Mitochondrial Activity in High sFlt-1 and Low HO-1 Environment"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4663-5752","authenticated-orcid":false,"given":"Lissette Carolina","family":"Sanchez-Aranguren","sequence":"first","affiliation":[{"name":"Aston Medical Research Institute, Aston Medical School, Birmingham B4 7ET, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Homira","family":"Rezai","sequence":"additional","affiliation":[{"name":"Aston Medical Research Institute, Aston Medical School, Birmingham B4 7ET, UK"},{"name":"Mirzyme Therapeutics, Innovation Birmingham Campus, Faraday Wharf, Holt Street, Birmingham B7 4BB, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9294-0475","authenticated-orcid":false,"given":"Shakil","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Aston Medical Research Institute, Aston Medical School, Birmingham B4 7ET, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0441-4000","authenticated-orcid":false,"given":"Faisal A.","family":"Alzahrani","sequence":"additional","affiliation":[{"name":"King Fahad Center for Medical Research, King Abdulaziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2135-2649","authenticated-orcid":false,"given":"Anna","family":"Sparatore","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Science, University of Milan, 20122 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keqing","family":"Wang","sequence":"additional","affiliation":[{"name":"Aston Medical Research Institute, Aston Medical School, Birmingham B4 7ET, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8755-8546","authenticated-orcid":false,"given":"Asif","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Aston Medical Research Institute, Aston Medical School, Birmingham B4 7ET, UK"},{"name":"Mirzyme Therapeutics, Innovation Birmingham Campus, Faraday Wharf, Holt Street, Birmingham B7 4BB, UK"},{"name":"King Fahad Center for Medical Research, King Abdulaziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1080\/09513590.2018.1441401","article-title":"New data about preeclampsia: Some possibilities of prevention","volume":"34","author":"Schindler","year":"2018","journal-title":"Gynecol. Endocrinol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/AOG.0b013e3181a45b25","article-title":"Hypertensive disorders and severe obstetric morbidity in the United States","volume":"113","author":"Kuklina","year":"2009","journal-title":"Obstet. Gynecol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00006254-200301000-00022","article-title":"Molecular epidemiology of preeclampsia","volume":"58","author":"Wilson","year":"2003","journal-title":"Obstet. Gynecol. Surv."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ajog.2017.06.011","article-title":"Health and economic burden of preeclampsia: No time for complacency","volume":"217","author":"Li","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_5","first-page":"329","article-title":"The Rising Burden of Preeclampsia in the United States Impacts Both Maternal and Child Health","volume":"33","author":"Shih","year":"2016","journal-title":"Am. J. Perinatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/msj.21345","article-title":"Recognizing global burden of cardiovascular disease and related chronic diseases","volume":"79","author":"Kelly","year":"2012","journal-title":"Mt. Sinai J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/1524839907303794","article-title":"The economic burden of chronic cardiovascular disease for major insurers","volume":"8","author":"Trogdon","year":"2007","journal-title":"Health Promot. Pract."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ijcard.2012.10.046","article-title":"Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations","volume":"168","author":"Finegold","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Bellamy, L., Casas, J.P., Hingorani, A.D., and Williams, D.J. (2007). Pre-eclampsia and risk of cardiovascular disease and cancer in later life: Systematic review and meta-analysis. BMJ, 335.","DOI":"10.1136\/bmj.39335.385301.BE"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.jacc.2019.09.052","article-title":"Long-Term Cardiovascular Risk in Women with Hypertension During Pregnancy","volume":"74","author":"Honigberg","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/CIRCULATIONAHA.118.038080","article-title":"Preeclampsia and Cardiovascular Disease in a Large UK Pregnancy Cohort of Linked Electronic Health Records: A CALIBER Study","volume":"140","author":"Leon","year":"2019","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1753944708094227","article-title":"Preeclampsia and future cardiovascular risk: Formal risk factor or failed stress test?","volume":"2","author":"Craici","year":"2008","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/bmj.323.7323.1213","article-title":"Long term mortality of mothers and fathers after pre-eclampsia: Population based cohort study","volume":"323","author":"Irgens","year":"2001","journal-title":"BMJ"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0143-4004(97)80091-4","article-title":"Heparin-binding angiogenic growth factors in pregnancy: A review","volume":"18","author":"Ahmed","year":"1997","journal-title":"Placenta"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1R","DOI":"10.1203\/01.PDR.0000159567.85157.B7","article-title":"Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia","volume":"57","author":"Maynard","year":"2005","journal-title":"Pediatr Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/cvr\/cvq346","article-title":"Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling","volume":"89","author":"Sanders","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Lou, W.Z., Jiang, F., Hu, J., Chen, X.X., Song, Y.N., Zhou, X.Y., Liu, J., Bian, X., and Gao, J. (2019). Maternal Serum Angiogenic Factor sFlt-1 to PlGF Ratio in Preeclampsia: A Useful Marker for Differential Diagnosis and Prognosis Evaluation in Chinese Women. Dis. Markers, 2019.","DOI":"10.1155\/2019\/6270187"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1055\/s-0032-1328601","article-title":"Prenatal Clinical Assessment of sFlt-1 (Soluble fms-like Tyrosine Kinase-1)\/PlGF (Placental Growth Factor) Ratio as a Diagnostic Tool for Preeclampsia, Pregnancy-induced Hypertension, and Proteinuria","volume":"73","author":"Lehnen","year":"2013","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/HYPERTENSIONAHA.115.05883","article-title":"Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity","volume":"66","author":"Palmer","year":"2015","journal-title":"Hypertension"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/CIRCULATIONAHA.106.660134","article-title":"Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1","volume":"115","author":"Cudmore","year":"2007","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/5584_2016_168","article-title":"Evidence-Based Revised View of the Pathophysiology of Preeclampsia","volume":"956","author":"Ahmed","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/00016340701819262","article-title":"Early postpartum changes in circulating pro- and anti-angiogenic factors in early-onset and late-onset pre-eclampsia","volume":"87","author":"Wikstrom","year":"2008","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/HYPERTENSIONAHA.117.09741","article-title":"Low Soluble Fms-Like Tyrosine Kinase-1, Endoglin, and Endothelin-1 Levels in Women with Confirmed or Suspected Preeclampsia Using Proton Pump Inhibitors","volume":"70","author":"Saleh","year":"2017","journal-title":"Hypertension"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/uog.15981","article-title":"Association between angiogenic factors and signs of arterial aging in women with pre-eclampsia","volume":"50","author":"Akhter","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1096\/fj.03-0187fje","article-title":"Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling","volume":"17","author":"Yet","year":"2003","journal-title":"FASEB J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"778","DOI":"10.2337\/diabetes.54.3.778","article-title":"Absence of heme oxygenase-1 exacerbates myocardial ischemia\/reperfusion injury in diabetic mice","volume":"54","author":"Liu","year":"2005","journal-title":"Diabetes"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/hh1401.093314","article-title":"Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice","volume":"89","author":"Yet","year":"2001","journal-title":"Circ. Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Hull, T.D., Boddu, R., Guo, L., Tisher, C.C., Traylor, A.M., Patel, B., Joseph, R., Prabhu, S.D., Suliman, H.D., and Piantadosi, C.A. (2016). Heme oxygenase-1 regulates mitochondrial quality control in the heart. JCI Insight, 1.","DOI":"10.1172\/jci.insight.85817"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-18144-8_1","article-title":"H2S Synthesizing Enzymes: Biochemistry and Molecular Aspects","volume":"230","author":"Huang","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"13829","DOI":"10.1073\/pnas.1105121108","article-title":"Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function","volume":"108","author":"Suzuki","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.neuint.2009.12.011","article-title":"Effect of hydrogen sulfide on intracellular calcium homeostasis in neuronal cells","volume":"56","author":"Yong","year":"2010","journal-title":"Neurochem. Int."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Cheung, S.H., and Lau, J.Y.W. (2018). Hydrogen sulfide mediates athero-protection against oxidative stress via S-sulfhydration. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0194176"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"22344","DOI":"10.18632\/oncotarget.15765","article-title":"Protective effect of hydrogen sulphide against myocardial hypertrophy in mice","volume":"8","author":"Shao","year":"2017","journal-title":"Oncotarget"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1093\/emboj\/20.21.6008","article-title":"The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener","volume":"20","author":"Zhao","year":"2001","journal-title":"EMBO J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1096\/fj.06-6270fje","article-title":"Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation","volume":"20","author":"Zanardo","year":"2006","journal-title":"FASEB J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"15560","DOI":"10.1073\/pnas.0705891104","article-title":"Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function","volume":"104","author":"Elrod","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"21972","DOI":"10.1073\/pnas.0908047106","article-title":"Hydrogen sulfide is an endogenous stimulator of angiogenesis","volume":"106","author":"Papapetropoulos","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Giuffre, A., and Vicente, J.B. (2018). Hydrogen Sulfide Biochemistry and Interplay with Other Gaseous Mediators in Mammalian Physiology. Oxid. Med. Cell Longev., 2018.","DOI":"10.1155\/2018\/6290931"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00592-013-0501-y","article-title":"Hydrogen sulfide induces heme oxygenase-1 in human kidney cells","volume":"51","author":"Shaw","year":"2014","journal-title":"Acta Diabetol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3892\/br.2013.87","article-title":"Hydrogen sulfide upregulates heme oxygenase-1 expression in rats with volume overload-induced heart failure","volume":"1","author":"Zhang","year":"2013","journal-title":"Biomed. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.freeradbiomed.2008.11.013","article-title":"Pharmacological profile of a novel H(2)S-releasing aspirin","volume":"46","author":"Sparatore","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejphar.2010.08.039","article-title":"Activity of a new hydrogen sulfide-releasing aspirin (ACS14) on pathological cardiovascular alterations induced by glutathione depletion in rats","volume":"648","author":"Rossoni","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.freeradbiomed.2010.02.014","article-title":"Modulation of thiol homeostasis induced by H2S-releasing aspirin","volume":"48","author":"Giustarini","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Sanchez-Aranguren, L.C., Espinosa-Gonzalez, C.T., Gonzalez-Ortiz, L.M., Sanabria-Barrera, S.M., Riano-Medina, C.E., Nunez, A.F., Ahmed, A., Vasquez-Vivar, J., and L\u00f3pez, M. (2018). Soluble Fms-Like Tyrosine Kinase-1 Alters Cellular Metabolism and Mitochondrial Bioenergetics in Preeclampsia. Front. Physiol., 9.","DOI":"10.3389\/fphys.2018.00083"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jacc.2011.03.032","article-title":"The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure","volume":"58","author":"Ky","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/00365513.2016.1190863","article-title":"Sflt-1 in heart failure: Relation with disease severity and biomarkers","volume":"76","author":"Gruson","year":"2016","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11357-018-0021-3","article-title":"Measurement of respiratory function in isolated cardiac mitochondria using Seahorse XFe24 Analyzer: Applications for aging research","volume":"40","author":"Sakamuri","year":"2018","journal-title":"Geroscience"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Boutagy, N.E., Rogers, G.W., Pyne, E.S., Ali, M.M., Hulver, M.W., and Frisard, M.I. (2015). Using Isolated Mitochondria from Minimal Quantities of Mouse Skeletal Muscle for High throughput Microplate Respiratory Measurements. J. Vis. Exp., 104.","DOI":"10.3791\/53216"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20110162","article-title":"Assessing mitochondrial dysfunction in cells","volume":"435","author":"Brand","year":"2011","journal-title":"Biochem. J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cpmo.21","article-title":"Analysis of mtDNA\/nDNA Ratio in Mice","volume":"7","author":"Quiros","year":"2017","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Siasos, G., Tsigkou, V., Kosmopoulos, M., Theodosiadis, D., Simantiris, S., Tagkou, N.M., Tsimpiktsioglou, A., Stampouloglou, P.K., Oikonomou, E., and Mourouzis, K. (2018). Mitochondria and cardiovascular diseases-from pathophysiology to treatment. Ann. Transl. Med., 6.","DOI":"10.21037\/atm.2018.06.21"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cmet.2005.03.002","article-title":"Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle","volume":"1","author":"Arany","year":"2005","journal-title":"Cell Metab."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.tcm.2012.07.003","article-title":"PGC-1 proteins and heart failure","volume":"22","author":"Riehle","year":"2012","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1089\/ars.2009.2940","article-title":"PGC-1 alpha regulates expression of myocardial mitochondrial antioxidants and myocardial oxidative stress after chronic systolic overload","volume":"13","author":"Lu","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1095\/biolreprod.111.093039","article-title":"Maternal heme oxygenase 1 regulates placental vasculature development via angiogenic factors in mice","volume":"85","author":"Zhao","year":"2011","journal-title":"Biol. Reprod."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.str.0000442009.06663.48","article-title":"Guidelines for the prevention of stroke in women: A statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Bushnell","year":"2014","journal-title":"Stroke"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10654-013-9762-6","article-title":"Cardiovascular disease risk in women with pre-eclampsia: Systematic review and meta-analysis","volume":"28","author":"Brown","year":"2013","journal-title":"Eur. J. Epidemiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/HYPERTENSIONAHA.109.130765","article-title":"Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother","volume":"53","author":"Lykke","year":"2009","journal-title":"Hypertension"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e003497","DOI":"10.1161\/CIRCOUTCOMES.116.003497","article-title":"Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis","volume":"10","author":"Wu","year":"2017","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ahj.2008.06.042","article-title":"Cardiovascular sequelae of preeclampsia\/eclampsia: A systematic review and meta-analyses","volume":"156","author":"McDonald","year":"2008","journal-title":"Am. Heart, J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF03401783","article-title":"Induction of placental heme oxygenase-1 is protective against TNFalpha-induced cytotoxicity and promotes vessel relaxation","volume":"6","author":"Ahmed","year":"2000","journal-title":"Mol. Med."},{"key":"ref_63","first-page":"291","article-title":"Heme oxygenase-1 is critically involved in placentation, spiral artery remodeling, and blood pressure regulation during murine pregnancy","volume":"5","author":"Zenclussen","year":"2014","journal-title":"Front. Pharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/HYPERTENSIONAHA.117.10425","article-title":"Fetal Microsatellite in the Heme Oxygenase 1 Promoter Is Associated With Severe and Early-Onset Preeclampsia","volume":"71","author":"Kaartokallio","year":"2018","journal-title":"Hypertension"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1124\/jpet.108.148049","article-title":"Carbon monoxide rescues mice from lethal sepsis by supporting mitochondrial energetic metabolism and activating mitochondrial biogenesis","volume":"329","author":"Lancel","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol. Rev."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1172\/JCI112174","article-title":"Metabolic fate of extracted glucose in normal human myocardium","volume":"76","author":"Wisneski","year":"1985","journal-title":"J. Clin. Investig."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/BJ20141171","article-title":"Mitochondrial pyruvate transport: A historical perspective and future research directions","volume":"466","author":"McCommis","year":"2015","journal-title":"Biochem. J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/bph.12475","article-title":"Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy","volume":"171","author":"Fillmore","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Pfleger, J., He, M., and Abdellatif, M. (2015). Mitochondrial complex II is a source of the reserve respiratory capacity that is regulated by metabolic sensors and promotes cell survival. Cell Death Dis., 6.","DOI":"10.1038\/cddis.2015.202"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1095\/biolreprod.114.126227","article-title":"A Role of sFlt-1 in Oxidative Stress and Apoptosis in Human and Mouse Pre-Eclamptic Trophoblasts","volume":"93","author":"Jiang","year":"2015","journal-title":"Biol. Reprod."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.biopha.2017.10.118","article-title":"Role of endogenous hydrogen sulfide in cardiac mitochondrial preservation during ischemia reperfusion injury","volume":"97","author":"Nandi","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.yjmcc.2018.01.011","article-title":"Hydrogen sulfide regulates cardiac mitochondrial biogenesis via the activation of AMPK","volume":"116","author":"Shimizu","year":"2018","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Shen, Y., Shen, Z., Luo, S., Guo, W., and Zhu, Y.Z. (2015). The Cardioprotective Effects of Hydrogen Sulfide in Heart Diseases: From Molecular Mechanisms to Therapeutic Potential. Oxid. Med. Cell Longev., 2015.","DOI":"10.1155\/2015\/925167"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Guo, W., Kan, J.T., Cheng, Z.Y., Chen, J.F., Shen, Y.Q., Xu, J., Wu, D., and Zhu, Y. (2012). Hydrogen sulfide as an endogenous modulator in mitochondria and mitochondria dysfunction. Oxid. Med. Cell Longev., 2012.","DOI":"10.1155\/2012\/878052"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.2337\/db16-0020","article-title":"Hydrogen Sulfide Induces Keap1 S-sulfhydration and Suppresses Diabetes-Accelerated Atherosclerosis via Nrf2 Activation","volume":"65","author":"Xie","year":"2016","journal-title":"Diabetes"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.fct.2013.09.012","article-title":"Diallyl-disulfide, an organosulfur compound of garlic, attenuates airway inflammation via activation of the Nrf-2\/HO-1 pathway and NF-kappaB suppression","volume":"62","author":"Shin","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.tips.2015.05.007","article-title":"The role of H2S bioavailability in endothelial dysfunction","volume":"36","author":"Wang","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1161\/CIRCULATIONAHA.113.001631","article-title":"Dysregulation of hydrogen sulfide producing enzyme cystathionine gamma-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia","volume":"127","author":"Wang","year":"2013","journal-title":"Circulation"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11010-013-1686-7","article-title":"Exogenous hydrogen sulfide prevents cardiomyocyte apoptosis from cardiac hypertrophy induced by isoproterenol","volume":"381","author":"Lu","year":"2013","journal-title":"Mol. Cell Biochem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/bph.13688","article-title":"AP39, a mitochondria-targeting hydrogen sulfide (H2 S) donor, protects against myocardial reperfusion injury independently of salvage kinase signalling","volume":"174","author":"Karwi","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1681\/ASN.2013030291","article-title":"Hydrogen sulfide attenuates sFlt1-induced hypertension and renal damage by upregulating vascular endothelial growth factor","volume":"25","author":"Holwerda","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/bph.12869","article-title":"Hydrogen sulfide: Physiological properties and therapeutic potential in ischaemia","volume":"172","author":"Bos","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/ATVBAHA.112.300484","article-title":"Thioredoxin 1 is essential for sodium sulfide-mediated cardioprotection in the setting of heart failure","volume":"33","author":"Nicholson","year":"2013","journal-title":"Arterioscler Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1089\/ars.2019.7963","article-title":"Redox Regulation via Glutaredoxin-1 and Protein S-Glutathionylation","volume":"32","author":"Matsui","year":"2020","journal-title":"Antioxid Redox Signal."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1089\/ars.2009.2791","article-title":"Glutaredoxin regulates apoptosis in cardiomyocytes via NFkappaB targets Bcl-2 and Bcl-xL: Implications for cardiac aging","volume":"12","author":"Gallogly","year":"2010","journal-title":"Antioxid Redox Signal."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1089\/ars.2007.1642","article-title":"What is the functional significance of the unique location of glutaredoxin 1 (GRx1) in the intermembrane space of mitochondria?","volume":"9","author":"Pai","year":"2007","journal-title":"Antioxid Redox Signal."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/9\/7\/598\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:49:28Z","timestamp":1760176168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/9\/7\/598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":88,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["antiox9070598"],"URL":"https:\/\/doi.org\/10.3390\/antiox9070598","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,9]]}}}